ライフサイエンスコーパス: splenectomize

1 ected, sham-operated; and 4) PG-PS-injected, splenectomized.

2 Three were male; all were splenectomized.

3 injected, sham-operated; 2) saline-injected, splenectomized; 3) peptidoglycan-polysaccharide (PG-PS)-

4 ne suppressive treatment and a majority were splenectomized (8/11).

5 kin allografts also were rejected acutely by splenectomized aly/aly (aly/aly-spl(-)) mice devoid of a

6 Using splenectomized alymphoplasia mice, which are unable to m

7 and allograft survival were also studied in splenectomized alymphoplastic (aly/aly) recipients, whic

8 n to a xenograft occurs, we examined whether splenectomized alymphoplastic mice that possess no secon

9 etermining the fate of corneal allografts in splenectomized and eusplenic mice.

10 phology and PU.1 expression were observed in splenectomized and nonsplenectomized HbE/beta-thalassemi

11 Splenectomized and nonsplenectomized patients achieved p

12 ases, with no significant difference between splenectomized and nonsplenectomized patients.

13 gic agonists fail to control inflammation in splenectomized and nude animals.

14 Both splenectomized and SLP mice were protected against letha

15 B cell memory, we revaccinated controls and splenectomized and tonsillectomized individuals with TT.

16 1-3Gal column adsorptions; baboons were then splenectomized and underwent renal xenografting from inb

17 a cohort of 100 ALPS patients (including 33 splenectomized) and found that 12 (10 splenectomized) ha

18 eart transplant 4 months previously, was not splenectomized, and did not receive any pharmacologic im

19 and 3 (which were immunologically naive and splenectomized, and received triple drug immunosuppressi

20 severity of murine GVHD of unsplenectomized, splenectomized, and sham-operated recipients of allogene

21 s purification was repeatedly collected from splenectomized animals at periods of peak parasitemias.

22 it tumor necrosis factor (TNF) production in splenectomized animals during lethal endotoxemia.

23 Splenectomized animals were given 10 mg of methylprednis

24 Surprisingly, in splenectomized animals, increased expression of adhesion

25 ected cattle were transmission fed on naive, splenectomized animals.

26 and survived, a phenomenon also observed in splenectomized animals.

27 Application of our model to data on patients splenectomized as treatment for ITP shows promise in pre

28 Control subjects produced more IgM Ab than splenectomized autoimmune subjects (p = 0.01) but the sa

29 As shown previously, the splenectomized autoimmune subjects had fewer total, isot

30 Furthermore, splenectomized B6 GalT(-/-), Ig micro -chain mutant ( mi

31 tudies involving two unmodified baboons, one splenectomized baboon, and one baboon that received a ch

32 We conclude that, in an immunosuppressed, splenectomized baboon, repeated EIA using a specific alp

33 Groups of splenectomized baboons (n = at least 2 in each group) we

34 Splenectomized baboons (n=3) were treated with CPP.

35 rimary function in the spleen, neonates were splenectomized before immunization.

36 garotoxin or PNU-282987 were administered to splenectomized, brain-injured rats.

37 come were severe infections, particularly in splenectomized cases, acute renal failure, Evans syndrom

38 ted intravenously into nonsplenectomized and splenectomized cats.

39 l blood passage of virulent Babesia bovis in splenectomized cattle results in attenuated derivatives

40 This effect is also present in splenectomized chimeric CD11c-DTR mice and is absent in

41 the isolation of recombinant parasites from splenectomized chimpanzees, a research avenue that is no

42 Nine alpha-chloralose-anesthetized, splenectomized dogs were subjected to hemorrhage of 10 m

43 y cause acute disease in immunosuppressed or splenectomized dogs.

44 From 2 patients (A and B), splenectomized for recurrent episodes of acquired TTP, t

45 ing 33 splenectomized) and found that 12 (10 splenectomized) had experienced 23 invasive bacterial in

46 dentical to those observed on red cells from splenectomized individuals and patients with SCD.

47 a lack of SLOs, intrapulmonary allografts in splenectomized LT mice were rejected and obliterated by

48 were tested using wild-type control mice and splenectomized lymphotoxin alpha knockout (LT) mice defi

49 ned from analyses of transitional B cells in splenectomized lymphotoxin alpha-deficient mice that lac

50 Splenectomized male B6D2F1 mice received 50 micrograms/k

51 ter infection in the bone marrow (BM) of the splenectomized, Mel-14-treated mice.

52 Normal hosts (CLN(+)), splenectomized mice (Sp(-)), and those without either CL

53 Splenectomized mice also fail to respond to i.p. challen

54 fic serum IgM was decreased only modestly in splenectomized mice and in mice that lacked spleen, lymp

55 Both splenectomized mice and mice with severe combined immuno

56 Mel-14 treatment of splenectomized mice did not affect clonal expansion of t

57 Furthermore, splenectomized mice fail to respond to such inflammatory

58 PS14 antibody response were also apparent in splenectomized mice immunized with PPS14-OVA.

59 Experiments using splenectomized mice or treatment with clodronate liposom

60 Analysis of splenectomized mice revealed delayed kinetics in the pro

61 the episodes of moderate level bacteremia by splenectomized mice suggested that MZ B cells do not pla

62 Splenectomized mice were used to test the splenic contri

63 n and lethality from polymicrobial sepsis in splenectomized mice, indicating that the spleen is criti

64 mors following injection into irradiated and splenectomized nude mice.

65 the BM was reduced in P/E-/- animals, either splenectomized or spleen-intact.

66 In the present study, splenectomized owl monkeys were infected with P. falcipa

67 occurred in 18% nonsplenectomized and 30% of splenectomized patients (P=0.68).

68 Splenectomized patients are susceptible to bloodstream i

69 Splenectomized patients had lower transfusional iron int

70 r, as normal cytokine responses were seen in splenectomized patients in remission from Hodgkin's dise

71 nti-D (WinRho, WinRho SD) therapy in 261 non-splenectomized patients treated at the New York Hospital

72 Altogether, 20,132 splenectomized patients were included.

73 In addition, 11 previously splenectomized patients were treated as a separate group

74 increase in greater than 70% of the Rh+ non-splenectomized patients.

75 y 2% peripheral blood progenitor cells) into splenectomized preconditioned (whole body irradiation (W

76 y 2% peripheral blood progenitor cells) into splenectomized preconditioned baboons, intended to induc

77 S1pr3(-/-) BMDCs did not attenuate IRI in splenectomized, Rag-1(-/-), or CD11c(+) DC-depleted mice

78 DSG and LEF were administered to C-depleted, splenectomized rat recipients of guinea pig cardiac xeno

79 detectable host T cells, and, in the case of splenectomized rats, only about one tenth of normal xeno

80 nd inferior vena cava, respectively, of the (splenectomized) recipient.

81 layed recovery in both nonsplenectomized and splenectomized recipients post-BMT, indicating that the

82 binoculation of whole blood into susceptible splenectomized recipients to be uninfected.

83 IgG Ab response between normal controls and splenectomized subjects (p = 0.51; p = 0.81).

84 M pneumococcal Ab responses in 26 vaccinated splenectomized subjects in comparison to memory B cell s

85 memory B cells subsets between controls and splenectomized subjects with spherocytosis.

86 production of T-independent IgM, serum from splenectomized subjects, who also have few IgM(+)IgD(+)C

87 and IgG or IgM Ab responses for controls or splenectomized subjects.

88 post-BMT, studies were performed using adult splenectomized syngeneic BMT recipients.

89 We describe a 36-year-old splenectomized woman with known SLE who presented with p

90 ogated by prior splenectomy; i.e., data from splenectomized xenograft recipients reflect the presence